CAPTRUST Financial Advisors
PLRX icon

CAPTRUST Financial Advisors’s Pliant Therapeutics PLRX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-612
Closed -$5K – 3500
2022
Q2 		$5K Buy
612
+572
+1,430% +$3.66K ﹤0.01% 4109
2022
Q1 		$0 Buy
+40
New +$408 ﹤0.01% 5083
2021
Q3 		– Sell
-76
Closed -$2K – 4729
2021
Q2 		$2K Buy
+76
New +$2.37K ﹤0.01% 4196

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CAPTRUST Financial Advisors's PLRX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Pliant Therapeutics (PLRX) in Q3 2022, closing a stake of 612 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in PLRX in Q2 2021 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 110 funds tracked by Wall St. Rank hold PLRX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Pliant Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 612 Pliant Therapeutics shares in Q3 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Pliant Therapeutics in Q2 2021 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's Pliant Therapeutics position peaked at $5K in Q2 2022.
  • 110 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.